[HTML][HTML] Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases

A Fischer, J Distler - Clinical rheumatology, 2019 - Springer
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

A Fischer, J Distler - Clinical Rheumatology, 2019 - search.ebscohost.com
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

[PDF][PDF] Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases

A Fischer, J Distler - Clinical Rheumatology, 2019 - d-nb.info
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases

A Fischer, J Distler - Clinical Rheumatology, 2019 - search.proquest.com
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases

A Fischer, J Distler - Clinical rheumatology, 2019 - pubmed.ncbi.nlm.nih.gov
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

A Fischer, J Distler - Clinical Rheumatology, 2019 - europepmc.org
Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …